Henry Schein, Inc. (0L3C.L)
USD 64.28
(0.45%)
USD 64.28
(0.45%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 416 Million USD | -22.68% |
| 2022 | 538 Million USD | -14.74% |
| 2021 | 631 Million USD | 56.27% |
| 2020 | 403.79 Million USD | -22.47% |
| 2019 | 520.79 Million USD | -2.82% |
| 2018 | 535.88 Million USD | 31.89% |
| 2017 | 406.29 Million USD | -19.83% |
| 2016 | 506.77 Million USD | 5.79% |
| 2015 | 479.05 Million USD | 2.79% |
| 2014 | 466.07 Million USD | 8.0% |
| 2013 | 431.55 Million USD | 11.2% |
| 2012 | 388.07 Million USD | 5.55% |
| 2011 | 367.66 Million USD | 12.85% |
| 2010 | 325.78 Million USD | 4.7% |
| 2009 | 311.15 Million USD | 27.97% |
| 2008 | 243.14 Million USD | 13.0% |
| 2007 | 215.17 Million USD | 31.4% |
| 2006 | 163.75 Million USD | 8.22% |
| 2005 | 151.32 Million USD | 18.05% |
| 2004 | 128.18 Million USD | -6.78% |
| 2003 | 137.51 Million USD | 16.55% |
| 2002 | 117.98 Million USD | 35.04% |
| 2001 | 87.37 Million USD | 53.96% |
| 2000 | 56.74 Million USD | 12.82% |
| 1999 | 50.3 Million USD | 208.59% |
| 1998 | 16.3 Million USD | 1730.0% |
| 1997 | -1 Million USD | -105.18% |
| 1996 | 19.3 Million USD | 289.22% |
| 1995 | -10.2 Million USD | 6.42% |
| 1994 | -10.9 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | 104 Million USD | 11.83% |
| 2024 Q1 | 93 Million USD | 416.67% |
| 2023 Q1 | 121 Million USD | 157.45% |
| 2023 Q3 | 137 Million USD | -2.14% |
| 2023 Q4 | 18 Million USD | -86.86% |
| 2023 FY | 416 Million USD | -22.68% |
| 2023 Q2 | 140 Million USD | 15.7% |
| 2022 Q1 | 181 Million USD | 22.93% |
| 2022 FY | 538 Million USD | -14.74% |
| 2022 Q4 | 47 Million USD | -68.67% |
| 2022 Q3 | 150 Million USD | -6.25% |
| 2022 Q2 | 160 Million USD | -11.6% |
| 2021 Q4 | 147.23 Million USD | -9.12% |
| 2021 FY | 631 Million USD | 56.27% |
| 2021 Q1 | 166 Million USD | 16.38% |
| 2021 Q2 | 156 Million USD | -6.02% |
| 2021 Q3 | 162 Million USD | 3.85% |
| 2020 Q2 | -10.79 Million USD | -108.29% |
| 2020 Q4 | 142.63 Million USD | 0.66% |
| 2020 Q3 | 141.69 Million USD | 1412.37% |
| 2020 FY | 403.79 Million USD | -22.47% |
| 2020 Q1 | 130.26 Million USD | -60.51% |
| 2019 Q4 | 329.86 Million USD | 134.68% |
| 2019 FY | 520.79 Million USD | -2.82% |
| 2019 Q1 | 109.78 Million USD | -17.44% |
| 2019 Q2 | 114.53 Million USD | 4.33% |
| 2019 Q3 | 140.55 Million USD | 22.72% |
| 2018 Q4 | 132.97 Million USD | 9.46% |
| 2018 Q2 | 141.21 Million USD | 0.71% |
| 2018 Q1 | 140.21 Million USD | 1742.86% |
| 2018 Q3 | 121.47 Million USD | -13.97% |
| 2018 FY | 535.88 Million USD | 31.89% |
| 2017 FY | 406.29 Million USD | -19.83% |
| 2017 Q4 | -8.53 Million USD | -106.18% |
| 2017 Q2 | 136.05 Million USD | -3.33% |
| 2017 Q3 | 138.03 Million USD | 1.45% |
| 2017 Q1 | 140.74 Million USD | 1.1% |
| 2016 Q3 | 133.71 Million USD | 11.34% |
| 2016 Q1 | 113.75 Million USD | -12.46% |
| 2016 Q2 | 120.09 Million USD | 5.58% |
| 2016 Q4 | 139.21 Million USD | 4.12% |
| 2016 FY | 506.77 Million USD | 5.79% |
| 2015 Q3 | 127.73 Million USD | 8.32% |
| 2015 Q1 | 103.44 Million USD | -22.2% |
| 2015 Q2 | 117.92 Million USD | 14.0% |
| 2015 Q4 | 129.94 Million USD | 1.73% |
| 2015 FY | 479.05 Million USD | 2.79% |
| 2014 FY | 466.07 Million USD | 8.0% |
| 2014 Q1 | 102.09 Million USD | -17.84% |
| 2014 Q2 | 116.23 Million USD | 13.85% |
| 2014 Q3 | 114.77 Million USD | -1.26% |
| 2014 Q4 | 132.96 Million USD | 15.85% |
| 2013 Q3 | 107.37 Million USD | -0.97% |
| 2013 Q4 | 124.26 Million USD | 15.73% |
| 2013 Q2 | 108.43 Million USD | 18.53% |
| 2013 Q1 | 91.47 Million USD | -18.66% |
| 2013 FY | 431.55 Million USD | 11.2% |
| 2012 Q3 | 96.77 Million USD | -1.34% |
| 2012 Q4 | 112.46 Million USD | 16.22% |
| 2012 Q1 | 80.75 Million USD | -22.9% |
| 2012 FY | 388.07 Million USD | 5.55% |
| 2012 Q2 | 98.08 Million USD | 21.47% |
| 2011 Q3 | 91.96 Million USD | -2.66% |
| 2011 Q2 | 94.47 Million USD | 23.5% |
| 2011 Q4 | 104.73 Million USD | 13.89% |
| 2011 FY | 367.66 Million USD | 12.85% |
| 2011 Q1 | 76.49 Million USD | -17.74% |
| 2010 Q2 | 84 Million USD | 37.93% |
| 2010 FY | 325.78 Million USD | 4.7% |
| 2010 Q4 | 92.99 Million USD | 5.8% |
| 2010 Q3 | 87.89 Million USD | 4.63% |
| 2010 Q1 | 60.9 Million USD | -29.52% |
| 2009 FY | 311.15 Million USD | 27.97% |
| 2009 Q1 | 54.85 Million USD | -3.62% |
| 2009 Q2 | 73.47 Million USD | 33.95% |
| 2009 Q3 | 96.42 Million USD | 31.23% |
| 2009 Q4 | 86.4 Million USD | -10.38% |
| 2008 Q4 | 56.91 Million USD | -15.67% |
| 2008 FY | 243.14 Million USD | 13.0% |
| 2008 Q2 | 64.57 Million USD | 25.52% |
| 2008 Q1 | 51.44 Million USD | -34.28% |
| 2008 Q3 | 67.48 Million USD | 4.52% |
| 2007 Q3 | 59.57 Million USD | 76.06% |
| 2007 Q1 | 43.41 Million USD | -31.09% |
| 2007 Q4 | 78.26 Million USD | 31.38% |
| 2007 FY | 215.17 Million USD | 31.4% |
| 2007 Q2 | 33.83 Million USD | -22.06% |
| 2006 Q3 | 39.28 Million USD | -13.12% |
| 2006 Q4 | 62.99 Million USD | 60.36% |
| 2006 Q2 | 45.21 Million USD | 178.11% |
| 2006 Q1 | 16.25 Million USD | -68.55% |
| 2006 FY | 163.75 Million USD | 8.22% |
| 2005 Q1 | 30.87 Million USD | 4.48% |
| 2005 Q2 | 37.77 Million USD | 22.34% |
| 2005 Q3 | 23.3 Million USD | -38.31% |
| 2005 Q4 | 51.7 Million USD | 121.88% |
| 2005 FY | 151.32 Million USD | 18.05% |
| 2004 Q2 | 38.73 Million USD | 36.43% |
| 2004 Q3 | 31.5 Million USD | -18.67% |
| 2004 FY | 128.18 Million USD | -6.78% |
| 2004 Q4 | 29.55 Million USD | -6.2% |
| 2004 Q1 | 28.39 Million USD | -20.11% |
| 2003 Q2 | 32.85 Million USD | 32.66% |
| 2003 Q1 | 24.76 Million USD | -20.01% |
| 2003 Q3 | 44.34 Million USD | 34.98% |
| 2003 FY | 137.51 Million USD | 16.55% |
| 2003 Q4 | 35.54 Million USD | -19.85% |
| 2002 Q1 | 19.73 Million USD | -27.29% |
| 2002 FY | 117.98 Million USD | 35.04% |
| 2002 Q4 | 30.96 Million USD | -21.07% |
| 2002 Q3 | 39.22 Million USD | 39.77% |
| 2002 Q2 | 28.06 Million USD | 42.25% |
| 2001 FY | 87.37 Million USD | 53.96% |
| 2001 Q1 | 14.13 Million USD | 11.0% |
| 2001 Q2 | 20.91 Million USD | 47.96% |
| 2001 Q3 | 25.19 Million USD | 20.49% |
| 2001 Q4 | 27.13 Million USD | 7.7% |
| 2000 Q2 | 16.38 Million USD | 43.72% |
| 2000 FY | 56.74 Million USD | 12.82% |
| 2000 Q1 | 11.39 Million USD | -26.46% |
| 2000 Q3 | 16.23 Million USD | -0.87% |
| 2000 Q4 | 12.73 Million USD | -21.59% |
| 1999 Q1 | 9.9 Million USD | 9800.0% |
| 1999 Q4 | 15.5 Million USD | 34.78% |
| 1999 Q3 | 11.5 Million USD | -13.53% |
| 1999 Q2 | 13.3 Million USD | 34.34% |
| 1999 FY | 50.3 Million USD | 208.59% |
| 1998 Q1 | 6.1 Million USD | 510.0% |
| 1998 Q2 | 7.8 Million USD | 27.87% |
| 1998 Q4 | 100 Thousand USD | -95.65% |
| 1998 Q3 | 2.3 Million USD | -70.51% |
| 1998 FY | 16.3 Million USD | 1730.0% |
| 1997 Q2 | 5.3 Million USD | 253.33% |
| 1997 FY | -1 Million USD | -105.18% |
| 1997 Q1 | 1.5 Million USD | -79.45% |
| 1997 Q4 | 1 Million USD | 110.42% |
| 1997 Q3 | -9.6 Million USD | -281.13% |
| 1996 Q4 | 7.3 Million USD | 37.74% |
| 1996 FY | 19.3 Million USD | 289.22% |
| 1996 Q1 | 2.7 Million USD | 145.45% |
| 1996 Q2 | 4.2 Million USD | 55.56% |
| 1996 Q3 | 5.3 Million USD | 26.19% |
| 1995 Q2 | -6.2 Million USD | 0.0% |
| 1995 Q4 | 1.1 Million USD | -8.33% |
| 1995 FY | -10.2 Million USD | 6.42% |
| 1995 Q1 | -6.2 Million USD | -121.43% |
| 1995 Q3 | 1.2 Million USD | 119.35% |
| 1994 Q1 | -2.7 Million USD | 0.0% |
| 1994 Q2 | -2.7 Million USD | 0.0% |
| 1994 FY | -10.9 Million USD | 0.0% |
| 1994 Q4 | -2.8 Million USD | -3.7% |
| 1994 Q3 | -2.7 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | 403.905% |
| Accuray Incorporated | -15.54 Million USD | 2776.102% |
| Align Technology, Inc. | 445.05 Million USD | 6.528% |
| Elevance Health Inc. | 5.98 Billion USD | 93.052% |
| AxoGen, Inc. | -21.71 Million USD | 2015.638% |
| Boston Scientific Corporation | 1.59 Billion USD | 73.886% |
| CVS Health Corporation | 8.34 Billion USD | 95.014% |
| Cardinal Health, Inc. | 852 Million USD | 51.174% |
| Centene Corporation | 2.7 Billion USD | 84.604% |
| DaVita Inc. | 691.53 Million USD | 39.844% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 92.064% |
| Hologic, Inc. | 789.5 Million USD | 47.308% |
| Humana Inc. | 2.48 Billion USD | 83.286% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 50.772% |
| Laboratory Corporation of America Holdings | 418 Million USD | 0.478% |
| Masimo Corporation | 81.5 Million USD | -410.429% |
| McKesson Corporation | 3 Billion USD | 86.143% |
| Patterson Companies, Inc. | 185.93 Million USD | -123.739% |
| Quest Diagnostics Incorporated | 854 Million USD | 51.288% |
| ResMed Inc. | 1.02 Billion USD | 59.254% |
| Teladoc Health, Inc. | -220.36 Million USD | 288.775% |
| Universal Health Services, Inc. | 717.79 Million USD | 42.045% |
| Veeva Systems Inc. | 525.7 Million USD | 20.868% |
| Baxter International Inc. | 2.65 Billion USD | 84.337% |
| Becton, Dickinson and Company | 1.48 Billion USD | 71.968% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 76.863% |
| Danaher Corporation | 4.2 Billion USD | 90.095% |
| Stryker Corporation | 3.16 Billion USD | 86.856% |
| Medtronic plc | 3.67 Billion USD | 88.683% |